0000905718-20-000564.txt : 20200610 0000905718-20-000564.hdr.sgml : 20200610 20200610160519 ACCESSION NUMBER: 0000905718-20-000564 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200609 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sinclair Andrew CENTRAL INDEX KEY: 0001762451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37490 FILM NUMBER: 20954723 MAIL ADDRESS: STREET 1: C/O SOLENO THERAPEUTICS INC. STREET 2: 1235 RADIO ROAD, SUITE 110 CITY: REDWOOD CITY STATE: CA ZIP: 94065 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sierra Oncology, Inc. CENTRAL INDEX KEY: 0001290149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 604-558-6536 MAIL ADDRESS: STREET 1: 2150 ? 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: ProNAi Therapeutics Inc DATE OF NAME CHANGE: 20040513 4 1 sierraonco_fm4jun92020.xml X0306 4 2020-06-09 0 0001290149 Sierra Oncology, Inc. SRRA 0001762451 Sinclair Andrew C/O SIERRA ONCOLOGY, INC. 2150-885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 BRITISH COLUMBIA, CANADA 1 0 0 0 Stock Option (right to buy 13.98 2020-06-09 4 A 0 6874 0 A 2030-06-09 Common Stock $.001 par value 6874 6874 D The option vests as to 8.333% of the total shares monthly, beginning on July 9, 2020, with 100% of the total shares vested and exercisable on June 9, 2021, subject to the reporting person's provision of service to the issuer on each vesting date. /s/ John Heard, as attorney-in-fact 2020-06-10